RMTI
Rockwell Medical Inc

6,897
Mkt Cap
$38.53M
Volume
159,112.00
52W High
$2.27
52W Low
$0.7801
PE Ratio
-5.88
RMTI Fundamentals
Price
$0.9375
Prev Close
$0.9777
Open
$0.9777
50D MA
$0.9341
Beta
1.64
Avg. Volume
235,467.64
EPS (Annual)
-$0.0252
P/B
1.00
Rev/Employee
$415,938.53
Loading...
Loading...
News
all
press releases
Rockwell Medical Extends Product Purchase Agreement Through 2026 With One of the Largest Dialysis Providers in the United States
Rockwell Medical, Inc. (the 'Company') (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers...
Business Wire·6d ago
News Placeholder
More News
News Placeholder
Rockwell Medical Appoints Joe Dawson to the Company's Board of Directors
Rockwell Medical, Inc. (the 'Company') (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers...
Business Wire·2mo ago
News Placeholder
Rockwell Medical (RMTI) Reports Q3 Loss, Lags Revenue Estimates
Rockwell Medical (RMTI) delivered earnings and revenue surprises of -25.00% and -5.20%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Rockwell Medical Announces Third Quarter 2025 Results
Rockwell Medical, Inc. (the 'Company') (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers...
Business Wire·2mo ago
News Placeholder
Rockwell Medical Names Rashad Brown Vice President, Manufacturing and Supply Chain
Rockwell Medical, Inc. (the 'Company') (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers...
Business Wire·2mo ago
News Placeholder
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q3 Loss, Misses Revenue Estimates
Maravai LifeSciences (MRVI) delivered earnings and revenue surprises of -33.33% and -18.63%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Rockwell Medical to Exhibit at ASN Kidney Week 2025
Rockwell Medical, Inc. (the 'Company') (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers...
Business Wire·2mo ago
News Placeholder
Rockwell Medical Named Fortune 'Best Workplaces in Manufacturing & Production' Second Year in a Row
Rockwell Medical, Inc. (the 'Company') (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers...
Business Wire·3mo ago
News Placeholder
Rockwell Medical to Release Third Quarter 2025 Results on Wednesday, November 12, 2025
Rockwell Medical, Inc. (the 'Company') (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers...
Business Wire·3mo ago
News Placeholder
All You Need to Know About Rockwell Medical (RMTI) Rating Upgrade to Buy
Rockwell Medical (RMTI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·3mo ago
<
1
2
...
>

Latest RMTI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.